Teva Pharmaceutical Industries Ltd (TEVA) company profile

Teva Pharmaceutical Industries is a global biopharmaceutical enterprise that develops, manufactures, and commercializes generic pharmaceuticals, biosimilars, innovative therapies, and over-the-counter healthcare products. Its commercial operations are organized into three primary geographic segments: the United States, Europe, and International Markets, supplemented by auxiliary operations in active pharmaceutical ingredient manufacturing, contract production, and product out-licensing. The company targets core therapeutic areas including central nervous system conditions, respiratory illnesses, and oncology. Teva provides medicines to diverse healthcare and commercial clients, including wholesale distributors, retail drug chains, independent pharmacies, mail-order distributors, hospitals, and physician practices.

The company maintains an extensive international footprint, operating with approximately 34,000 employees across 57 markets worldwide. Its commercial network spans substantial infrastructure throughout the United States, European markets, and over 35 countries within its International Markets division. Teva maintains its corporate headquarters in Israel.

Summary of the business section of Teva Pharmaceutical Industries's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of December 31, 2025, Teva’s global workforce consisted of 33,950 employees.”